Xiangdong Yang

1.3k total citations
57 papers, 975 citations indexed

About

Xiangdong Yang is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Xiangdong Yang has authored 57 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Nephrology, 9 papers in Cardiology and Cardiovascular Medicine and 8 papers in Molecular Biology. Recurrent topics in Xiangdong Yang's work include Chronic Kidney Disease and Diabetes (13 papers), Renal Diseases and Glomerulopathies (11 papers) and Neuropeptides and Animal Physiology (7 papers). Xiangdong Yang is often cited by papers focused on Chronic Kidney Disease and Diabetes (13 papers), Renal Diseases and Glomerulopathies (11 papers) and Neuropeptides and Animal Physiology (7 papers). Xiangdong Yang collaborates with scholars based in China and United States. Xiangdong Yang's co-authors include Tao Peng, Zhao Hu, Tingting Xie, Bei Jiang, Guangyi Liu, Chunhong Ma, Lifen Gao, Xiaohong Liang, Zhenzhong Li and Xiangyu Tang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiangdong Yang

52 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangdong Yang China 18 297 251 176 122 115 57 975
Rong Wang China 22 482 1.6× 441 1.8× 113 0.6× 120 1.0× 84 0.7× 71 1.3k
Yunman Wang China 20 421 1.4× 365 1.5× 72 0.4× 105 0.9× 106 0.9× 36 1.1k
Zhi Guo China 12 175 0.6× 195 0.8× 127 0.7× 133 1.1× 158 1.4× 24 874
Xia Zhong China 19 423 1.4× 158 0.6× 163 0.9× 104 0.9× 120 1.0× 42 1.1k
Xue‐qi Liu China 21 657 2.2× 330 1.3× 123 0.7× 123 1.0× 90 0.8× 33 1.2k
Yi‐Gang Wan China 18 472 1.6× 332 1.3× 96 0.5× 87 0.7× 59 0.5× 65 999
Jiagen Wen China 19 515 1.7× 211 0.8× 101 0.6× 108 0.9× 66 0.6× 47 1.1k
Rongshuang Huang China 18 572 1.9× 447 1.8× 162 0.9× 109 0.9× 91 0.8× 34 1.3k
Haijiang Wu China 18 612 2.1× 220 0.9× 114 0.6× 65 0.5× 162 1.4× 27 1.1k

Countries citing papers authored by Xiangdong Yang

Since Specialization
Citations

This map shows the geographic impact of Xiangdong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangdong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangdong Yang more than expected).

Fields of papers citing papers by Xiangdong Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangdong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangdong Yang. The network helps show where Xiangdong Yang may publish in the future.

Co-authorship network of co-authors of Xiangdong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangdong Yang. A scholar is included among the top collaborators of Xiangdong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangdong Yang. Xiangdong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Xin, Ke‐Qing Zhao, Chunjie Wang, et al.. (2025). Effectiveness and safety of finerenone in IgA nephropathy patients. Nephrology Dialysis Transplantation.
2.
Yang, Xiangdong, Lei Wu, Bo Wang, et al.. (2025). Lateral growth, linkage and driving force of anticlines in the western Qaidam Basin, Northern Tibetan Plateau. Journal of Structural Geology. 193. 105370–105370.
4.
Bai, Fang, Chunjie Wang, Xin Fan, et al.. (2024). Novel biomarkers related to oxidative stress and immunity in chronic kidney disease. Heliyon. 10(6). e27754–e27754.
5.
Yan, Lixiang, et al.. (2024). Atypical chronic myeloid leukemia found in a patient with eosinophilia for six years: a case report. BMC Geriatrics. 24(1). 595–595.
6.
Diao, Yujie, et al.. (2023). Identification of two novel SALL1 mutations in chinese families with townes-brocks syndrome and literature review. Orphanet Journal of Rare Diseases. 18(1). 250–250. 4 indexed citations
7.
Zhang, Peipei, Hao Lu, Yuanyuan Wu, et al.. (2023). COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis. International Journal of Molecular Sciences. 24(12). 10400–10400. 20 indexed citations
8.
Li, Shan, Chunjie Wang, Yimeng Zhang, et al.. (2023). APOC1 as a novel diagnostic biomarker for DN based on machine learning algorithms and experiment. Frontiers in Endocrinology. 14. 1102634–1102634. 5 indexed citations
9.
Lin, Fan, Yunqi Liu, Lili Tang, et al.. (2021). Rapamycin protects against aristolochic acid nephropathy in mice by potentiating mammalian target of rapamycin‑mediated autophagy. Molecular Medicine Reports. 24(1). 5 indexed citations
10.
Xu, Fuping, Hao Guo, Feng Feng, et al.. (2021). IDO1 as a new immune biomarker for diabetic nephropathy and its correlation with immune cell infiltration. International Immunopharmacology. 94. 107446–107446. 23 indexed citations
11.
Shi, Weiwei, Ling Guo, Guangyi Liu, et al.. (2018). Protective effect of calcitriol on podocytes in spontaneously hypertensive rat. Journal of the Chinese Medical Association. 81(8). 691–698. 11 indexed citations
12.
Peng, Tao, Xia Li, Zhao Hu, Xiangdong Yang, & Chengjun Ma. (2018). Predictive role of endothelin in left ventricular remodeling of chronic kidney disease. Renal Failure. 40(1). 183–186. 9 indexed citations
13.
Peng, Tao, et al.. (2016). IgG4-related disease: a case report with duration of more than 16 years and review of literature. SpringerPlus. 5(1). 804–804. 4 indexed citations
14.
Tian, Jun, et al.. (2015). Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation. Inflammation. 38(5). 1739–1747. 48 indexed citations
15.
Peng, Tao, Jie Wang, Junhui Zhen, Zhao Hu, & Xiangdong Yang. (2014). Effect of benazepril on the transdifferentiation of renal tubular epithelial cells from diabetic rats. Biomedical Reports. 2(4). 490–494. 3 indexed citations
16.
Guo, Ling, et al.. (2013). Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) on kidney tissue from systemic lupus erythematosus (SLE) patients. Clinical and Experimental Medicine. 14(4). 383–388. 22 indexed citations
17.
Peng, Tao, et al.. (2012). Relationship Between Psychiatric Disorders and Quality of Life in Nondialysis Patients With Chronic Kidney Disease. The American Journal of the Medical Sciences. 345(3). 218–221. 15 indexed citations
18.
Liu, Zhen, Huaxiang Liu, Xiangdong Yang, et al.. (2010). Effects of Insulin-Like Growth Factor-1 on Expression of Sensory Neuropeptides in Cultured Dorsal Root Ganglion Neurons in the Absence or Presence of Glutamate. International Journal of Neuroscience. 120(11). 698–702. 6 indexed citations
19.
Yang, Xiangdong, Zhen Liu, & Zhenzhong Li. (2009). Effects of norepinephrine on galanin expression in dorsal root ganglion neurons in vitro. Current Therapeutic Research. 70(1). 19–28. 3 indexed citations
20.
Yang, Xiangdong, Zhen Liu, Huaxiang Liu, et al.. (2007). Regulatory effect of nerve growth factor on release of substance P in cultured dorsal root ganglion neurons of rat. Neuroscience Bulletin. 23(4). 215–220. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026